In vivo detection of metastatic ovarian cancer by means of 5- aminolevulinic acid-induced fluorescence in a rat model

Journal of the American Association of Gynecologic Laparoscopists

Volumn 5, Issue 2, 1998, Pages 141-148

  Hornung, Rene ^a,c   Major, Attila L ^a   McHale, Michael ^b   Liaw, Lih Huei L ^a   Sabiniano, Leslie A ^a   Tromberg, Bruce J ^a   Berns, Michael W ^a   Tadir, Yona ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; METASTASIS; MICROSCOPY; NONHUMAN; OVARY CANCER; RAT; ULTRAVIOLET RADIATION;

EID: 0031779134     PISSN: 10743804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-3804(98)80080-7     Document Type: Article

References (51)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1996. CA Cancer J Clin 46:5-27, 1996
2. Schwartz PE: Cytoreductive surgery for the management of stage IV ovarian cancer [editorial]. Gynecol Oncol 64:1-3, 1997
3. Curtin JP, Malik R, Venkatraman ES, et al: Stage IV ovarian cancer: Impact of surgical debulking. Gynecol Oncol 64:9-12, 1997
4. Muderspach L, Muggia FM, Conti PS: Second-look laparotomy for stage III epithelial ovarian cancer: Rationale and current issues. Cancer Treat Rev 21:499-511, 1996
5. Nicoletto MO, Tumolo S, Talamini R, et al: Surgical second look in ovarian cancer: A randomized study in patients with laparoscopic complete remission-A northeastern oncology cooperative group-ovarian cancer cooperative group study. J Clin Oncol 15:994-999, 1997
6. Abu-Rustum NR, Barakat RR, Siegel PL, et al: Second-look operation for epithelial ovarian cancer: Laparoscopy or laparotomy? Obstet Gynecol 88:549-553, 1996
7. DiSaia PJ, Creasman WT: Epithelial Ovarian Cancer. St. Louis, Mosby-Year Book, 1993
8. Niloff JM, Bast RC Jr, Schaetzl EM, et al: Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol 151:981-986, 1985
9. Berek JS, Knapp RC, Malkasian GD, et al: CA 125 serum levels correlated with second-look operations among ovarian cancer patients. Obstet Gynecol 67:685-689, 1986
10. Rome RM, Koh H, Fortune D, et al: CA 125 serum levels and secondary laparotomy in epithelial ovarian tumours. Aust NZ J Obstet Gynaecol 27:142-145, 1987
11. Rubin SC, Hoskins WJ, Hakes TB, et al: Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. Am J Obstet Gynecol 160:667-671, 1989
12. Engblom PR, Grenman SE, Klemi PJ, et al: The role of cul-de-sac aspiration cytology in the follow-up of ovarian cancer. Acta Oncol 34:783-785, 1995
13. Pass HI: Photodynamic therapy in oncology; mechanisms and clinical use. J Natl Cancer Inst 85:443-456, 1993
14. Lin CW: Photodynamic therapy of malignant tumors - Recent developments. Cancer Cells 3:437-444, 1991
15. Delaney TF, Glatstein E: Photodynamic therapy of cancer. Compr Ther 14:43-55, 1988
16. Tromberg BJ, Orenstein A, Kimel S, et al: In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem Photobiol 52:375-385, 1990
17. Wyss DM, Sun CH, Wyss P, et al: Accumulation of 5-aminolevulinic acid-induced proloporphyrin IX in normal and neoplastic human endometrial epithelial cells. Biochem Biophys Res Commun 224:819-824, 1996
18. Zuna RE, Behrens A: Peritoneal washing cytology in gynecologic cancers: Long-term follow-up of 355 patients. J Natl Cancer Inst 88:980-987, 1996
19. Jichlinski P, Mizeret J, Forrer M, et al: Superficial bladder tumors. Pathological and clinical review and presentation of a new diagnostic method: Fluorescence photodetection of transitional epithelial carcinomas based on protoporphyrin IX induction with delta-aminolevulinic acid (5-ALA). Rev Med Suisse Romande 115:233-237, 1995
20. Kriegmair M, Baumgartner R, Lumper W, et al: Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol 77:667-671, 1996
21. Kriegmair M, Baumgartner R, Knuchel R, et al: Photodynamic diagnosis of urothelial neoplasms after intravesicular instillation of 5-aminolevulinic acid. Urologe A 33:270-275, 1994
22. Fehr MK, Wyss P, Tromberg, BJ, et al: Selective photosensitizer localization in the human endometrium after intrauterine application of 5-aminolevulinic acid. Am J Obstet Gynecol 175:1253-1259, 1996
23. Wyss P, Tromberg BJ, Wyss MT, et al: Photodynamic destruction of endometrial tissue with topical 5-aminolevulinic acid in rats and rabbits. Am J Obstet Gynecol 171:1176-1183, 1994
24. Van Hillegersberg R, Van den Berg JW, Kort WJ, et al: Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology 103:647-651, 1992
25. von Rueden DG, McBrearty FX, Clements BM, et al: Photodetection of carcinoma of the colon in a rat model: A pilot study. J Surg Oncol 53:43-46, 1993
26. Hua Z, Gibson SL, Foster TH, et al: Effectiveness of delta-aminolevulinic acid induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res 55:1723-1731, 1995
27. Major AL, Rose GS, Chapman CF, et al: In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA). Gynecol Oncol 66:122-132, 1996
28. Kriegmair M, Baumgartner R, Knuechel R, et al: Fluorescence photodetection of neoplastic urothelial lesions after intravesical instillation of 5-aminolevulinic acid. Urology 44:836-841, 1994
29. Testa JR, Getts LA, Salazar H, et al: Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. Cancer Res 54:2778-2784, 1994
30. Rose GS, Tocco LM, Granger GA, et al: Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol 175:593-599, 1996
31. Steinbach P, Kriegmair M, Baumgartner R, et al: Intravesical instillation of 5-aminolevulinic acid: The fluorescent metabolite is limited to urothelial cells. Urology 44:676-681, 1994
32. Bachor R, Flotte TJ, Scholz M, et al: Comparison of intravenous and intravesical administration of chloroaluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model. J Urol 147:1404-1410, 1992
33. Bachor R, Hautmann R, Hasan T: Comparison of two routes of photosensitizer administration for photodynamic therapy of bladder cancer. Urol Res 22:21-23, 1994
34. Chang SC, MacRobert AJ, Bown SG: Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid. J Urol 155:1744-1748, 1996
35. Chang SC, MacRobert AJ, Bown SG: Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: Light diffusion and histological changes. J Urol 155:1749-1753, 1996
36. Cho YH, Straight RC, Smith JA Jr: Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model. J Urol 147:743-746, 1992
37. Iinuma S, Bachor R, Flotte T, et al: Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urol 153:802-806, 1995
38. Pope AJ, Bown SG: The morphological and functional changes in rat bladder after photodynamic therapy with phthalocyanine photosensitization. J Urol 145:1064-1070, 1991
39. Tseng MT, Schuschke DA, Reed MW, et al: The influence of photodynamic therapy on the ultrastructure of the normal rat bladder. J Photochem Photobiol B 9:295-305, 1991
40. Patrice T, Foultier MT, Yactayo S, et al: Endoscopic photodynamic therapy with haematoporphyrin derivative in gastroenterology. J Photochem Photobiol B 6:157-165, 1990
41. Barr H, Bown SG, Krasner N, et al: Photodynamic therapy for colorectal disease. Int J Colorectal Dis 4:15-19, 1989
42. Bedwell I, MacRobert AJ, Phillips D, et al: Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumour model. Br J Cancer 65:818-824, 1992
43. Dougherty TJ: Photosensitizers: Therapy and detection of malignant tumors. Photochem Photobiol 45:879-889, 1987
44. Boente MP, Yeh K, Hogan WM, et al: Current status of staging laparotomy in colorectal and ovarian cancer. Cancer Treat Res 82:337-357, 1996
45. Abu-Rustum NR, Barakat RR, Siegel PL, et al: Second-look operation for epithelial cancer: Laparoscopy or laparotomy? Obstet Gynecol 88:549-553, 1996
46. Abeler V, Kjorstad KE, Nesland JM: Small cell carcinoma of the ovary. A report of six cases. Int J Gynecol Pathol 7:315-329, 1988
47. Richards-Kortum R, Mitchell MF, Ramanujam N, et al: In vivo fluorescence spectroscopy: Potential for non-invasive, automated diagnosis of cervical intraepithelial neoplasia and use as a surrogate endpoint biomarker. J Cell Biochem Suppl 19:111-119, 1994
48. Ramanujam N, Mitchell MF, Mahadevan A, et al: In vivo diagnosis of cervical intraepithelial neoplasia using 337-nm-excited laser-induced fluorescence. Proc Natl Acad Sci USA 91:10193-10197, 1994
49. Ramanujam N, Mitchell MF, Mahadevan A, et al: Fluorescence spectroscopy: A diagnostic tool for cervical intraepithelial neoplasia (CIN). Gynecol Oncol 52:31-38, 1994
50. Ramanujam N, Mitchell MF, Mahadevan A, et al: Spectroscopic diagnosis of cervical intraepithelial neoplasia (CIN) in vivo using laser-induced fluorescence spectra at multiple excitation wavelengths. Lasers Surg Med 19:63-74, 1996
51. Molpus KL, Kato D, Hamblin MR, et al: Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Cancer Res 56:1075-1082, 1996